Role of Physical Therapy Intervention and Gene Therapy on Muscular Dystrophies, Current Status and Future Perspectives: A Narrative Review
Role of Physical Therapy Intervention and Gene Therapy
DOI:
https://doi.org/10.54393/pjhs.v5i01.1253Keywords:
Muscular Dystrophy, Gene Therapy, Adenovirus, Molecular PathogenesisAbstract
Muscular dystrophies form a collection of genetic disorders marked by progressive muscle weakness and degeneration. The identification of the majority of responsible genes has enabled precise diagnosis and subtype-specific anticipatory care. Over the years, various therapies, encompassing genetic, cellular, and pharmacological approaches, have emerged for muscular dystrophies. This narrative review thoroughly explores the ongoing developments in muscular dystrophy therapeutics, including antisense therapy, CRISPR, gene replacement, cell therapy, based gene therapy Adeno-associated viral vector (AAV), and disease-modifying small molecule compounds. The review is particularly significant as it reflects advancements in supportive medicine that have altered the standard of care, leading to an overall improvement in the quality of life, clinical course and survival for affected individuals. In this study, our focus is on the clinical manifestations, molecular pathogenesis, diagnostic strategies, and therapeutic advancements related to this group of conditions. The study involved the review of 20 pertinent English-language articles, publications, reports, and online resources.
References
Mercuri E, Bönnemann CG, Muntoni F. Muscular dystrophies. The Lancet. 2019 Nov; 394(10213): 2025-38. doi: 10.1016/S0140-6736(19)32910-1. DOI: https://doi.org/10.1016/S0140-6736(19)32910-1
Swathi S, Chandrasekaran GK, Senthil P. Advanced Physiotherapy Intervention for Muscular Dystrophy. Potential Therapeutic Strategies for Muscular Dystrophy. IntechOpen; 2023. doi: 10.5772/intechopen.113080. DOI: https://doi.org/10.5772/intechopen.113080
Younger DS. Childhood muscular dystrophies. In Handbook of Clinical Neurology. Elsevier 2023 Jan; 195: 461-96. doi: 10.1016/B978-0-323-98818-6.00024-8. DOI: https://doi.org/10.1016/B978-0-323-98818-6.00024-8
Zambon AA and Muntoni F. Congenital muscular dystrophies: What is new? Neuromuscular Disorders. 2021 Oct; 31(10): 931-42. doi: 10.1016/j.nmd.2021.07.009. DOI: https://doi.org/10.1016/j.nmd.2021.07.009
Salari N, Fatahi B, Valipour E, Kazeminia M, Fatahian R, Kiaei A et al. Global prevalence of Duchenne and Becker muscular dystrophy: a systematic review and meta-analysis. Journal of Orthopedic Surgery and Research. 2022 Dec; 17(1): 1-2. doi: 10.1186/s13018-022-02996-8. DOI: https://doi.org/10.1186/s13018-022-02996-8
Datta N and Ghosh PS. Update on muscular dystrophies with focus on novel treatments and biomarkers. Current Neurology and Neuroscience Reports. 2020 Jun; 20: 1-2. doi: 10.1007/s11910-020-01034-6. DOI: https://doi.org/10.1007/s11910-020-01034-6
Osorio AN, Cantillo JM, Salas AC, Garrido MM, Padilla JV. Consensus on the diagnosis, treatment and follow-up of patients with Duchenne muscular dystrophy. Neurología. 2019 Sep; 34(7): 469-81. doi: 10.1016/j.nrleng.2018.01.001. DOI: https://doi.org/10.1016/j.nrleng.2018.01.001
Comi GP, Niks EH, Vandenborne K, Cinnante CM, Kan HE, Willcocks RJ et al. Givinostat for Becker muscular dystrophy: A randomized, placebo-controlled, double-blind study. Frontiers in Neurology. 2023 Jan; 14: 1095121. doi: 10.3389/fneur.2023.1095121. DOI: https://doi.org/10.3389/fneur.2023.1095121
Crudele JM and Chamberlain JS. AAV-based gene therapies for the muscular dystrophies. Human Molecular Genetics. 2019 Oct; 28(R1): R102-7. doi: 10.1093/hmg/ddz128. DOI: https://doi.org/10.1093/hmg/ddz128
Lanza G, Pino M, Fisicaro F, Vagli C, Cantone M, Pennisi M et al. Motor activity and Becker’s muscular dystrophy: lights and shadows. The Physician and Sportsmedicine. 2020 Apr; 48(2): 151-60. doi: 10.1080/00913847.2019.1684810. DOI: https://doi.org/10.1080/00913847.2019.1684810
Abd El Aziz AS, Abd El Aziz HG, Ali MS. Efficacy of two intervention approaches on functional walking capacity and balance in children with Duchene muscular dystrophy. Journal of Musculoskeletal & Neuronal Interactions. 2021; 21(3): 343.
Bayley K, Parkinson S, Jacoby P, Cross D, Morris S, Vorster N et al. Benefits of powered standing wheelchair devices for adolescents with Duchenne muscular dystrophy in the first year of use. Journal of Pediatrics and Child Health. 2020 Sep; 56(9): 1419-25. doi: 10.1111/jpc.14963. DOI: https://doi.org/10.1111/jpc.14963
Baeza-Barragán MR, Manzanares MT, Vergara CR, Casuso-Holgado MJ, Martín-Valero R. The use of virtual reality technologies in the treatment of Duchenne muscular dystrophy: systematic review. JMIR mHealth and uHealth. 2020 Dec; 8(12): e21576. doi: 10.2196/21576 DOI: https://doi.org/10.2196/21576
Camela F, Gallucci M, Ricci G. Cough and airway clearance in Duchenne muscular dystrophy. Paediatric Respiratory Reviews. 2019 Aug; 31: 35-9. doi: 10.1016/j.prrv.2018.11.001. DOI: https://doi.org/10.1016/j.prrv.2018.11.001
Dhargave P, Nalini A, Nagarathna R, Sendhilkumar R, James TT, Raju TR et al. Effect of yoga and physiotherapy on pulmonary functions in children with duchenne muscular dystrophy–a comparative study. International Journal of Yoga. 2021 May; 14(2): 133. doi: 10.4103/ijoy.IJOY_49_20. DOI: https://doi.org/10.4103/ijoy.IJOY_49_20
Carroll K, Yiu EM, Ryan MM, Kennedy RA, de Valle K. The effects of calf massage in boys with Duchenne muscular dystrophy: a prospective interventional study. Disability and Rehabilitation. 2021 Dec; 43(26): 3803-9. doi: 10.1080/09638288.2020.1753829. DOI: https://doi.org/10.1080/09638288.2020.1753829
de Souza MA, Cezarani A, da Silva Lizzi EA, de Queiroz Davoli GB, Mattiello SM, Jones R et al. The use of the gait profile score and gait variable score in individuals with Duchenne Muscular Dystrophy. Journal of Biomechanics. 2020 Jan; 98: 109485. doi: 10.1016/j.jbiomech.2019.109485. DOI: https://doi.org/10.1016/j.jbiomech.2019.109485
Alemdaroğlu-Gürbüz İ, İpek C, Bulut N, Karaduman A, Yılmaz Ö. The Impact of “Fear of Falling” on Physical Performance, Balance, and Ambulation in Duchenne Muscular Dystrophy. Neuropediatrics. 2022 Aug; 53(05): 330-7. doi: 10.1055/s-0042-1750722. DOI: https://doi.org/10.1055/s-0042-1750722
van As D, Okkersen K, Bassez G, Schoser B, Lochmüller H, Glennon JC et al. Clinical outcome evaluations and CBT response prediction in myotonic dystrophy. Journal of Neuromuscular Diseases. 2021 Jan; 8(6): 1031-46. doi: 10.3233/JND-210634. DOI: https://doi.org/10.3233/JND-210634
Dias RM, Hoshi RA, Vanderlei LC, Monteiro CB, Alvarez MP, Crocetta TB et al. Influence of different types of corticosteroids on heart rate variability of individuals with duchenne muscular dystrophy—a pilot cross sectional study. Life. 2021 Jul; 11(8): 752. doi: 10.3390/life11080752. DOI: https://doi.org/10.3390/life11080752
Kracht KD, Eichorn NL, Berlau DJ. Perspectives on the advances in the pharmacotherapeutic management of Duchenne muscular dystrophy. Expert Opinion on Pharmacotherapy. 2022 Oct; 23(15): 1701-10. doi: 10.1080/14656566.2022.2130246. DOI: https://doi.org/10.1080/14656566.2022.2130246
Shimizu-Motohashi Y, Komaki H, Motohashi N, Takeda SI, Yokota T, Aoki Y. Restoring dystrophin expression in Duchenne muscular dystrophy: current status of therapeutic approaches. Journal of Personalized Medicine. 2019 Jan; 9(1): 1. doi: 10.3390/jpm9010001. DOI: https://doi.org/10.3390/jpm9010001
Sun C, Serra C, Lee G, Wagner KR. Stem cell-based therapies for Duchenne muscular dystrophy. Experimental Neurology. 2020 Jan; 323: 113086. doi: 10.1016/j.expneurol.2019.113086. DOI: https://doi.org/10.1016/j.expneurol.2019.113086
Ganassi M and Zammit PS. Involvement of muscle satellite cell dysfunction in neuromuscular disorders: Expanding the portfolio of satellite cell-opathies. European Journal of Translational Myology. 2022 Mar; 32(1). doi: 10.4081/ejtm.2022.10064. DOI: https://doi.org/10.4081/ejtm.2022.10064
Shehata ZH, Rabea H, El Sherif R, Abdelrahim ME, Dawoud DM. Estimating Societal Cost of Illness and Patients’ Quality of Life of Duchenne Muscular Dystrophy in Egypt. Value in Health Regional Issues. 2023 Jan; 33: 10-6. doi: 10.1016/j.vhri.2022.08.006. DOI: https://doi.org/10.1016/j.vhri.2022.08.006
Shah MN and Yokota T. Cardiac therapies for Duchenne muscular dystrophy. Therapeutic Advances in Neurological Disorders. 2023 Jul; 16: 17562864231182934. doi: 10.1177/17562864231182934. DOI: https://doi.org/10.1177/17562864231182934
Gianola S, Castellini G, Pecoraro V, Monticone M, Banfi G, Moja L. Effect of muscular exercise on patients with muscular dystrophy: a systematic review and meta-analysis of the literature. Frontiers in Neurology. 2020 Nov; 11: 958. doi: 10.3389/fneur.2020.00958. DOI: https://doi.org/10.3389/fneur.2020.00958
Nakajima T, Sankai Y, Takata S, Kobayashi Y, Ando Y, Nakagawa M et al. Cybernic treatment with wearable cyborg Hybrid Assistive Limb (HAL) improves ambulatory function in patients with slowly progressive rare neuromuscular diseases: a multicentre, randomised, controlled crossover trial for efficacy and safety (NCY-3001). Orphanet Journal of Rare Diseases. 2021 Dec; 16(1): 1-8. doi: 10.1186/s13023-021-01928-9. DOI: https://doi.org/10.1186/s13023-021-01928-9
Lessard I, Gaboury S, Gagnon C, Bouchard K, Chapron K, Lavoie M et al. Effects and acceptability of an individualized home-based 10-week training program in adults with myotonic dystrophy type 1. Journal of Neuromuscular Diseases. 2021 Jan; 8(1): 137-49. doi: 10.3233/JND-200570. DOI: https://doi.org/10.3233/JND-200570
Biressi S, Filareto A, Rando TA. Stem cell therapy for muscular dystrophies. The Journal of Clinical Investigation. 2020 Nov; 130(11): 5652-64. doi: 10.1172/JCI142031. DOI: https://doi.org/10.1172/JCI142031
Iavarone M, Monda E, Vritz O, Albert DC, Rubino M, Verrillo F et al. Medical treatment of patients with hypertrophic cardiomyopathy: An overview of current and emerging therapy. Archives of Cardiovascular Diseases. 2022 Sep; 115: 529-37. doi: 10.1016/j.acvd.2022.06.003. DOI: https://doi.org/10.1016/j.acvd.2022.06.003
Hammer S, Toussaint M, Vollsæter M, NESBJØRG M, Røksund OD, Reychler G et al. Exercise training in Duchenne muscular dystrophy: A systematic review and meta-analysis. Journal of Rehabilitation Medicine. 2022; 54. doi: 10.2340/jrm.v53.985. DOI: https://doi.org/10.2340/jrm.v53.985
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Pakistan Journal of Health Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments